However, no association was found with the use of the LAPSS and the proportion of patients treated with intravenous tPA among confirmed stroke cases (RR 1.13; 95% CI [0.71 - 1.80]; p = 0.601, moderate certainty evidence). The gene discussed is PLAT; the disease is stroke disorder.